Article · 2018
Editor
Mina T Kelleni
Department of Pharmacology, Minia University, Egypt
About
As published by the journal they serve.
Dr. Mina T Kelleni is One of the top 0.7 % COVID-19 experts among over 416,090 authors worldwide (Expertscape). Egyptian general practitioner, senior consultant and assistant professor of pharmacology whose professional medical practice evolved together with his passion for innovative pharmacotherapy since 2006. Author of dozens of academic publications with ubiquitous medical research aiming mostly at drug discovery for several chronic and acute diseases ranging from diabetes mellitus, cancer to COVID-19 as well as raising awareness about drug pharmacovigilance in the developing countries
Research interests
Journals they serve
The seats these journals name them in.
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article · 2017
Diabetogenic Drugs and Hormones, what Every Physician should know and be Aware of?
Article · 2016
General Medicine, Open Access: A Wonderful 2016 Harvest and New Heights to Look Forward In 2017
Article · 2016
Simeprevir, Sofosbuvir and Ribavirin as First Line Therapy of HCV Infection, is it Justifiable Enough Basing on Safety and Efficacy?
Article · 2016
Rituximab: Is it Possible to Link Both Autoimmune Haemolytic Anemia and Aplastic Anemia Regarding the Etiology and Management?
Article · 2015
Fludarabine Monotherapy Fails to Control a Case of Relapsing Non-Hodgkins Lymphoma
Article · 2022
Personalized expanded Kelleni’s immunomodulatory COVID-19 protocol safely used to manage severe COVID-22: A case-report.
Article · 2022
Personalized expanded Kelleni's immunomodulatory COVID-19 protocol safely used to manage severe COVID-22: A case-report
Article · 2018
Back to Oral Hypoglycemic Drugs after Ten Years of Insulin Injections: An Egyptian Case Study
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.